Lilly Loses $120 Billion in Value as Rival Obesity Drugs Impress
(Bloomberg) -- Eli Lilly & Co. is down more than $120 billion in market value and its status as the poster child of the weight-loss drug frenzy is under threat with at least two rivals posting encoura...